Dr. Julissa Andree Jimenez , MD
Dermatology • Chicago, IL
225 E Chicago Ave # 107
Chicago, IL 606112991
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 16, 2017; this date does not establish years in practice.
-
Published CMS data list 198 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ketoconazole — 59 prescription fills, including refills.
- Triamcinolone Acetonide — 44 prescription fills, including refills.
- Clobetasol Propionate — 24 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 8 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under Dermatology in Chicago, IL (2024, 146 clinicians with data). Median for this group: 220. Middle half: 94 to 508.
Fewer Part D prescriptions than 70% of clinicians listed under Dermatology in Illinois (2024, 472 clinicians with data). Median for this group: 471. Middle half: 163 to 902.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 38 in 2022 to 198 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022–2024.
Practice Location & Contact Primary Location
225 E Chicago Ave # 107
Chicago, IL 606112991
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
210 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$50,487 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $108.72 across 5 records.
By nature of payment
- Food and Beverage: $108.72 across 5 records.
Reporting-company totals (3 largest of 5)
- Sanofi and Genzyme US Companies: $31.79 across 1 record.
- Pfizer Inc.: $21.64 across 1 record.
- Janssen Pharmaceuticals, Inc: $20.88 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2017
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Can order Medicare-covered services
CMS lists Dr. Jimenez as eligible to order or refer durable medical equipment (DME) for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Chicago and Illinois
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Dermatology in Chicago, IL (2024, 146 clinicians with data). Median for this group: 220. Middle half: 94 to 508.
Fewer Part D prescriptions than 70% of clinicians listed under Dermatology in Illinois (2024, 472 clinicians with data). Median for this group: 471. Middle half: 163 to 902.
Part D drug cost
Close to the middle for clinicians listed under Dermatology in Chicago, IL (2024, 146 clinicians with data). Median for this group: $45,589. Middle half: $2,629 to $188,011.
Close to the middle for clinicians listed under Dermatology in Illinois (2024, 472 clinicians with data). Median for this group: $69,025. Middle half: $5,860 to $275,598.
234 active clinicians are listed under Dermatology with a practice address in Chicago, IL (651 in Illinois).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Chicago
10.7% of these 234 clinicians have the CMS telehealth indicator.
55.1% of these 234 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 421% from 38 in 2022 to 198 in 2024.
- 2022: 38
- 2023: 135
- 2024: 198
-
30-day fills
30-day fills increased 452% from 38 in 2022 to 210 in 2024.
- 2022: 38
- 2023: 142
- 2024: 210
-
Part D drug cost
Part D drug cost went from $693 in 2022 to $50,487 in 2024.
- 2022: $693
- 2023: $3,604
- 2024: $50,487
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 100% from $48,991.00 in 2021 to $108.72 in 2025.
- 2021: $48,991.00
- 2022: $24.80
- 2023: $440.96
- 2024: $499.25
- 2025: $108.72
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $108.72.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $31.79 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
CIBINQO | General | $21.64 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $20.88 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
TALTZ | General | $20.12 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $14.29 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ketoconazole | Ketoconazole | 59 | 1,504 | $1,353.83 | 32 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 1,268 | $825.26 | 37 |
| Clobetasol Propionate | Clobetasol Propionate | 24 | 662 | $739.17 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 507 | $376.89 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | 555 | $68.91 | — |
| Tacrolimus | Tacrolimus | 14 | 355 | $2,539.32 | — |
| Clindamycin Phosphate | Clindamycin Phosphate | 12 | 420 | $564.00 | — |
| Dupixent Pen | Dupilumab | 12 | 336 | $44,019.48 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-09-18NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 225 E CHICAGO AVE # 107, CHICAGO, IL 606112991 (Tel: 3122271107)
Registered at 225 E CHICAGO AVE # 107, CHICAGO, IL 606112991
Dermatology (license number reported to NPPES: IL 036152300)
NPI status registered as active in NPPES database
Registered at 5153 N 9TH AVE FL 6, PENSACOLA, FL 325048785 (Tel: (850) 416-7658)
Registered at 5153 NORTH 9TH AVE, 6TH FLOOR NEMOURS, PENSACOLA, FL 32504 (Tel: 8504167658)
Recorded as JULISSA JIMENEZ, MD
Student in an Organized Health Care Education/Training Program (license number reported to NPPES: FL TRN24497)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Chicago
- Dr. Grace Wei, MD MPH MS
- Dr. Noor Tazudeen, MD
- Arlene Ruiz De Luzuriaga
- Dr. Donald Lei, MD
- Dr. Beth Adams, MD
- Dr. Caroline Robinson, MD
More public profiles in Illinois
Directory navigation, in NPI number order.
- Bilal Hai, MD Radiology - Diagnostic Radiology · Schaumburg
- Kathryn Forsman, MD Psychiatry & Neurology - Neurology · Chicago
- Harsimran Singh, MD Hospitalist · Chicago
- Michelle Panek, APRN, CNP Nurse Practitioner · Palos Heights
- Amanda Amiti, FNP, PMHNP-BC Nurse Practitioner - Psychiatric/Mental Health · Orland Park
- Sarah Knobbe, FNP-BC Nurse Practitioner · Warrenville
- Megan Carter, LSW Social Worker - Clinical · Decatur
- Kelsey Byrne Physician Assistant · Chicago
- Tina Hall Nurse Practitioner - Family · Mount Vernon
- John Patrick Uy, MD Internal Medicine · Chicago
- Alyssa Vasylyuk, PA-C Physician Assistant · Rockford
- Robert Kupfert, DPT Physical Therapist · Lake In The Hills
Mailing Address
225 E Chicago Ave # 107
Chicago, IL 606112991